miR-194 was found to inhibit cellular proliferation in OSCC by suppressing acylglycerol kinase (AGK) expression via the PI3K/AKT/FoxO3a signaling pathway acting as a tumor suppressor (Chi, 2015). Here, AKT1 is linked to neoplasm.